Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

2.59
Delayed Data
As of Apr 20
 -0.06 / -2.26%
Today’s Change
0.57
Today|||52-Week Range
4.24
-7.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash55.3M26.6M15.1M14.9M
 
 
 
 
 
Short Term Investment Cash882.0K-28.7M-11.5M-147.0K
 
 
 
 
 
Cash & Short Term Investments55.3M34.1M23.3M33.5M
 
 
 
 
 
 
ReceivablesReceivables2.3M4.6M1.0M402.0K
 
 
 
 
 
 
InventoriesInventories--0.000.000.00--
 
Current AssetsOther Current Assets1.5M1.6M1.9M16.3M
 
 
 
 
 
Current Assets59.1M40.4M26.3M50.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross26.9M187.0K----
 
 
 
Depreciation-15.6M-164.0K----
 
 
 
Other Assets239.0K143.0K970.0K15.0K
 
 
 
 
 
Total Assets70.7M40.5M27.3M50.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.2M1.4M2.2M2.4M
 
 
 
 
 
Short Term Debt11.7M2.1M2.1M0.00
 
 
 
 
Accrued Expenses7.6M3.2M4.6M9.5M
 
 
 
 
 
Other Current Liabilities23.6M8.0M5.1M28.4M
 
 
 
 
 
Other Liabilities40.4M12.4M10.3M32.1M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt8.9M7.4M11.9M18.5M
 
 
 
 
 
Other Liabilities540.0K618.0K5.3M39.1M
 
 
 
 
 
Total Liabilities50.1M23.3M29.2M91.0M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity20.6M17.2M-1.9M-40.8M
 
 
 
 
 
Total Shareholder Equity20.6M17.2M-1.9M-40.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding52.3M58.2M75.9M118.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.